Critics Warn Dementia Lifestyle Study May Waste 55 Million Kronor Due to Methodological Flaws

A recent Swedish study funded with 55 million kronor aimed at reducing dementia risk through lifestyle interventions has drawn sharp criticism from health experts for serious methodological shortcomings. Critics highlight that the study did not investigate the actual development of dementia among participants and excluded individuals exhibiting early dementia signs, raising questions about its validity.

The critics, including prominent researchers Magnus Gisslén, Staffan Nilsson, and Agnes Wold from the University of Gothenburg, point to a 2021 Cochrane review analyzing nine similar studies. This review found that only two evaluated the progression to dementia and neither showed significant effects from lifestyle interventions. They argue that the National Board of Health and Welfare (Socialstyrelsen) has uncritically presented the study's findings in a positive light, ignoring broader evidence.

Concerns extend beyond research validity. Experts warn of potential negative consequences such as increased healthcare costs, the burden on primary care through screening of healthy older adults, and the diversion of resources from other critical healthcare needs. The critique underscores a need for more rigorous studies before large investments are made in lifestyle interventions for dementia prevention.

As dementia remains a pressing public health issue, this debate highlights tensions in allocating funding effectively and ensuring interventions are backed by solid evidence to truly benefit public health.